Literature DB >> 7994907

Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).

M Okawa-Takatsuji1, S Aotsuka, S Uwatoko, M Sumiya, R Yokohari.   

Abstract

An attempt was made to determine whether addition of purified autoantibodies against U1-ribonucleoprotein (RNP) and negatively charged molecules (cardiolipin and double-stranded (ds) DNA) to cultures of peripheral blood monocytes could enhance the synthesis of cytokines in patients with MCTD and normal healthy volunteers. It was found that: (i) at the baseline, levels of cytokines such as IL-1 alpha, IL-1 beta and IL-6 extracellularly released by or associated with monocytes were significantly higher in MCTD patients than in normal subjects; (ii) addition of antibodies against U1-RNP to cultures of MCTD monocytes resulted in a significant overall increase of the released and cell-associated IL-1 alpha, IL-1 beta and IL-6. On the other hand, addition of antibodies against cardiolipin or dsDNA to cultures of MCTD monocytes resulted in a significant increase of released and/or cell-associated IL-1 alpha and IL-1 beta; (iii) addition of these autoantibodies to cultures of normal monocytes resulted in a significant overall increase of released and cell-associated IL-1 alpha, IL-1 beta and IL-6. The extent of enhancement of cytokines released by or associated with monocytes was greater in normal subjects than in MCTD patients; (iv) a F(ab')2 preparation of autoantibodies against U1-RNP also enhanced the level of released and cell-associated IL-1 alpha. Our findings that both autoantibodies against U1-RNP and negatively charged molecules were able to enhance the synthesis of cytokines by monocytes suggest that these autoantibodies might cause derangement of endothelial cells and lead to proliferative vasculopathy, which is a characteristic of pulmonary hypertension in MCTD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994907      PMCID: PMC1534514          DOI: 10.1111/j.1365-2249.1994.tb05508.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson
Journal:  J Rheumatol       Date:  1990-03       Impact factor: 4.666

2.  Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

Authors:  P Hainaut; E Lavenne; J M Magy; E G Lebacq
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

3.  Definition of the antigenic polypeptides in the Sm and RNP ribonucleoprotein complexes.

Authors:  P J White; S O Hoch
Journal:  Biochem Biophys Res Commun       Date:  1981-09-16       Impact factor: 3.575

4.  Deciphering the mysteries of RNA-containing lupus antigens.

Authors:  E A Lerner; M R Lerner; J A Hardin; C A Janeway; J A Steitz
Journal:  Arthritis Rheum       Date:  1982-07

5.  Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors.

Authors:  D Alarcon-Segovia; A Ruiz-Arguelles; E Fishbein
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

6.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

7.  Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds.

Authors:  S Aotsuka; T Funahashi; N Tani; M Okawa-Takatsuji; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

8.  Pulmonary hypertension in a lupus clinic: experience with twenty-four patients.

Authors:  R A Asherson; T W Higenbottam; A T Dinh Xuan; M A Khamashta; G R Hughes
Journal:  J Rheumatol       Date:  1990-10       Impact factor: 4.666

9.  Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.

Authors:  J Alcocer-Varela; E Martinez-Cordero; D Alarcon-Segovia
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

10.  Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis.

Authors:  A Shore; S Jaglal; E C Keystone
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

View more
  1 in total

1.  Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

Authors:  M Okawa-Takatsuji; S Aotsuka; M Fujinami; S Uwatoko; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.